Image 4_The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target.tif
Introduction<p>Osteosarcoma (OS) is a malignant bone tumor with high metastatic potential and poor long-term survival. The tumor immune microenvironment and metabolic reprogramming are increasingly recognized as key drivers of OS progression, yet the molecular links between these systems remai...
Saved in:
| Main Author: | Yunpeng Zou (3723007) (author) |
|---|---|
| Other Authors: | Jianning Kang (16623540) (author), Shaopeng Zhu (22060040) (author), Xuechen Ren (11930768) (author), Zheng Li (26302) (author), Jiayao Niu (22060043) (author), Xuanzhe Qin (22060046) (author), Hongbo Li (130443) (author), Lu Xiang (14394279) (author), Wei Jiang (14986) (author), Jiangbo Zhong (22060049) (author), Ying Zhang (40767) (author), Kai Zhao (53042) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Image 1_The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target.tif
by: Yunpeng Zou (3723007)
Published: (2025) -
Image 3_The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target.tif
by: Yunpeng Zou (3723007)
Published: (2025) -
Image 2_The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target.tif
by: Yunpeng Zou (3723007)
Published: (2025) -
Image 5_The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target.tif
by: Yunpeng Zou (3723007)
Published: (2025) -
Data Sheet 2_The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target.pdf
by: Yunpeng Zou (3723007)
Published: (2025)